Earnings

Faeth Therapeutics Q3 EPS $(0.79) Misses $(0.71) Estimate

Nov 3, 2026 · 07:33 AM ET· updated 2h ago

Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.71) by 11.27 percent. This is a 78.18 percent increase over losses of $(3.62) per share

Why It Matters

Faeth lost more money per share than experts expected this quarter. The company is improving though, since losses shrank a lot compared to last year.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

FTH19.88

+0.65 (+3.38%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.